Lifesci Capital Upgrades Perspective Therapeutics (NYSE:CATX) to “Strong-Buy”
Lifesci Capital upgraded shares of Perspective Therapeutics (NYSE:CATX – Free Report) to a strong-buy rating in a research report sent to investors on Thursday,Zacks.com reports. A number of other research analysts have also recently weighed in on the stock. Scotiabank began coverage on shares of Perspective Therapeutics in a report on Friday. They issued a […]
Lifesci Capital upgraded shares of Perspective Therapeutics (NYSE:CATX – Free Report) to a strong-buy rating in a research report sent to investors on Thursday,Zacks.com reports. A number of other research analysts have also recently weighed in on the stock. Scotiabank began coverage on shares of Perspective Therapeutics in a report on Friday. They issued a […]
